• Press
  • Offices
  • Contact
  • Legal notice
  • EN
    • DE
  • UPC
  • Firm
    • Main Focus
    • History
    • Guiding Principle
    • Awards and Rankings
  • Our Practice
    • Legal Areas
    • Industries
  • Our Team
  • Career
    • Working with us
  • News & Knowledge
    • News
    • Events
    • UPC-Update
    • IP-Update
    • Brexit-Update
    • Publications
    • B&B Bulletin
  • Menu Menu
FIND EXPERTS
  • UPC
  • Firm
    • Main Focus
    • History
    • Guiding Principle
    • Awards and Rankings
  • News & Knowledge
    • News
    • Events
    • UPC-Update
    • IP-Update
    • Brexit-Update
    • Publications
    • B&B Bulletin
  • FIND EXPERTS
  • Contact
  • Our Practice
    • Legal Areas
    • Industries
  • Our Team
  • Career
    • Working with us
  • Offices
  • EN
    • DE

Swiss Biotech Day: Dr. Ute Kilger on 3 May 2022 with her own panel on “Waiver for Covid Patents: Bleak future for biopharma industry?”

3. May 2022/in Events

The European Union has reached an agreement with the USA, India and South Africa on the framework conditions for a patent suspension for Covid19 vaccines. Finalisation and approval by the WHO member states is still pending.

But how will a restriction of intellectual property rights affect the biopharmaceutical industry? What are the consequences for future new medicines that are urgently needed in the global fight against serious diseases? And what measures could prevent the weakening of intellectual property while contributing to the supply of new, highly effective drugs to all people?

BOEHMERT & BOEHMERT patent attorney and partner Dr. Ute Kilger will discuss these questions at the Swiss Biotech Day on 3 May from 12:30 (CEST).
Jürgen M. Schneider, BIO Deutschland e. V., Dr. Rainer Strohmenger, Wellington Partners, as well as Philip Beushausen, dreissig24 GmbH, will complete the top-class panel.

More information on the Swiss Biotech Day 2022, its programme and a registration option can be found here.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2022-05-03 00:00:002022-08-04 14:46:48Swiss Biotech Day: Dr. Ute Kilger on 3 May 2022 with her own panel on “Waiver for Covid Patents: Bleak future for biopharma industry?”

Author

BOEHMERT & BOEHMERT

Contents

More articles

  • Berlinale 2023: Producers' Brunch on 20.02.2023 with Dr.… 26. January 2023
  • Workshop in Barcelona - register now! 12. December 2022
  • GINSEP & TIE Germany Masterclass: Dr. Daniel Herrmann to… 5. December 2022

Menu

  • Firm
  • Our Practice
  • Career
  • News & Knowledge
  • FIND EXPERTS

Informations

  • Press
  • Contact
  • Legal notice
  • Data Protection
  • General Terms and Conditions
  • Contact

Legal Areas

  • Employee Inventions
  • Data Protection
  • Designs
  • Domains
  • Information Technology
  • Anti-Trust
  • Licencing
  • Trade Marks
  • Patent Valuation
  • Patents & Utility Models
  • Patent Litigation
  • Product Piracy
  • Copyright
  • Unfair Competition

© Copyright 2023– BOEHMERT & BOEHMERT

Scroll to top

We only use functional cookies and no third party services. Learn more in our privacy policy.

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.